These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 3872647)
1. [Value of plasma exchange in neurologic complications of acute disseminated lupus erythematosus in children]. Couillault G; Gouyon JB; Chalopin JM; Rifle G; Nivelon JL Arch Fr Pediatr; 1985 Jan; 42(1):41-3. PubMed ID: 3872647 [TBL] [Abstract][Full Text] [Related]
2. [Plasma exchange therapy in children and adolescents with systemic lupus erythematosus (SLE)]. Pistor K; Neudorf U Monatsschr Kinderheilkd; 1987 Jan; 135(1):47-50. PubMed ID: 3494196 [TBL] [Abstract][Full Text] [Related]
3. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study]. Zielinski C; Müller C; Smolen J Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527 [TBL] [Abstract][Full Text] [Related]
4. Combined plasma-exchange and immunosuppressive therapy for neurologic involvement of systemic lupus erythematosus. Marson P; Tenderini ML; Doria A; Rigoli AM; De Silvestro G Recenti Prog Med; 1994 Jan; 85(1):72-3. PubMed ID: 8184184 [No Abstract] [Full Text] [Related]
5. [Acute polyvisceral lupus erythematosus in a young 12-year-old girl. The value of plasma exchange]. Palcoux JB; de Champs C; Roche M; Vanlieferinghen P Pediatrie; 1983 Mar; 38(2):119-23. PubMed ID: 6622140 [TBL] [Abstract][Full Text] [Related]
6. [Acute neurologic complications and coagulation disorders in a child with lupus. Spectacular improvement after a plasma exchange]. Blanchard P; Lebranchu Y; Marchand S; Grenier B Arch Fr Pediatr; 1986 Apr; 43(4):292-3. PubMed ID: 3767592 [No Abstract] [Full Text] [Related]
9. [Corticotherapy and plasma exchange in systemic lupus erythematosus]. Rahbar K; Belghiti D; Sobel A Ann Med Interne (Paris); 1986; 137 Suppl():41-8. PubMed ID: 3545007 [No Abstract] [Full Text] [Related]
10. SLE: the value of immunological tests and aspects of management. Edmonds JP Aust N Z J Med; 1978; 8 Suppl 1():116-23. PubMed ID: 365157 [No Abstract] [Full Text] [Related]
11. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328 [TBL] [Abstract][Full Text] [Related]
12. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus]. Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542 [No Abstract] [Full Text] [Related]
13. Rheumatoid arthritis and systemic lupus erythematosus (SLE). Beer TC; Gumpel JM Proc R Soc Med; 1973 Sep; 66(9):910. PubMed ID: 4141773 [No Abstract] [Full Text] [Related]
14. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients. Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040 [TBL] [Abstract][Full Text] [Related]
20. The value of anti-DNA antibody titers in the early diagnosis, treatment and follow-up of systemic lupus erythematosus. Pick AI; Levo Y; Weiss C Isr J Med Sci; 1974 Jul; 10(7):725-30. PubMed ID: 4137310 [No Abstract] [Full Text] [Related] [Next] [New Search]